BioSpace News Archive

H.I.G. BioHealth Partners recently announced the sale of Vertiflex, Inc. to Boston Scientific for a total equity value of approximately $465 million in cash and additional payments contingent on the Company attaining certain commercial goals.

CytoSorbents Corporation, announced that its Chief Executive Officer, Dr. Phillip Chan, MD, PhD, will present an overview of the company at the Raymond James Life Sciences and MedTech Conference in New York, NY. Both Dr. Chan and Chief Financial Officer Kathleen Bloch will meet with investors in 1x1 meetings throughout the day.

AstraZeneca and Merck announced that the European Commission has approved LYNPARZA as monotherapy for the maintenance treatment of adult patients with advanced BRCA1/2-mutated high-grade epithelial ovarian, fallopian tube or primary peritoneal cancer who are in response following completion of first-line platinum-based chemotherapy.

Sage Therapeutics announced that the Company will present at the BMO Prescriptions for Success Healthcare Conference on Tuesday, June 25, 2019 at 8:40 a.m. EST in New York, NY.

Novigenix SA announced the appointment of Francois Martelet, M.D., to its Board of Directors as a non-executive director.

Children’s National ranked in all 10 specialties, retaining top 10 honors in neonatology, neurology and neurosurgery, nephrology, cancer, and pulmonology and lung surgery

Essity’s Half-year Report for 2019 will be published on July 18 at approximately 7:00 CET.

Cognizant Strengthens Industry 4.0 Offering with New End-to-End Smart Factory Capabilities

Pivotal Clinical Efficacy Phase 3 Clinical Trial Results Expected in 2020

U.S.News & World Report Releases 2019-2020 Survey of “Best Children’s Hospitals” [18-June-2019] NEW YORK , June 18, 2019 /PRNewswire/ -- Hospital for Special Surgery’s (HSS) Lerner Children’s Pavilion continues to earn national recognition as a leader in pediatric orthopedics, ranking among the nation’s finest in the 2019-2020 U.S.News & World Repor